Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sadhna Sharma

Showing results (61-70 of 139) with videos related to

Pageof 14
Sort By:
Tuberculosis (Edinburgh, Scotland)|November 19, 2003
Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosisRajesh Pandey, A Zahoor, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|September 13, 2005
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosisZahoor Ahmad, A Zahoor, Sadhna Sharma, et al.
International Journal of Clinical Pediatric Dentistry|June 1, 2022
Comparative Evaluation of Two Antibiotic Pastes for Root Canal DisinfectionMridula Goswami, C P Baveja, Urvashi Bhushan, et al.
International Journal of Pharmaceutics|July 19, 2005
Nano-encapsulation of azole antifungals: potential applications to improve oral drug deliveryRajesh Pandey, Zahoor Ahmad, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|April 21, 2006
Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two dosesZahoor Ahmad, Rajesh Pandey, Sadhna Sharma, et al.
The Indian Journal of Chest Diseases & Allied Sciences|July 10, 2008
Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potentialZahoor Ahmad, Rajesh Pandey, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|December 25, 2007
Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticlesZahoor Ahmad, Rajesh Pandey, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomesSumeet Labana, Rajesh Pandey, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|November 24, 2004
Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosisAnjali Sharma, Rajesh Pandey, Sadhna Sharma, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Mycobacterium tuberculosis MymA is a TLR2 agonist that activate macrophages and a T<sub>H</sub>1 responseIti Saraav, Swati Singh, Kirti Pandey, et al.
Pageof 14

Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
Tuberculosis (Edinburgh, Scotland)|November 19, 2003
Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosisRajesh Pandey, A Zahoor, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|September 13, 2005
Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosisZahoor Ahmad, A Zahoor, Sadhna Sharma, et al.
International Journal of Clinical Pediatric Dentistry|June 1, 2022
Comparative Evaluation of Two Antibiotic Pastes for Root Canal DisinfectionMridula Goswami, C P Baveja, Urvashi Bhushan, et al.
International Journal of Pharmaceutics|July 19, 2005
Nano-encapsulation of azole antifungals: potential applications to improve oral drug deliveryRajesh Pandey, Zahoor Ahmad, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|April 21, 2006
Pharmacokinetic and pharmacodynamic behaviour of antitubercular drugs encapsulated in alginate nanoparticles at two dosesZahoor Ahmad, Rajesh Pandey, Sadhna Sharma, et al.
The Indian Journal of Chest Diseases & Allied Sciences|July 10, 2008
Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potentialZahoor Ahmad, Rajesh Pandey, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|December 25, 2007
Novel chemotherapy for tuberculosis: chemotherapeutic potential of econazole- and moxifloxacin-loaded PLG nanoparticlesZahoor Ahmad, Rajesh Pandey, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomesSumeet Labana, Rajesh Pandey, Sadhna Sharma, et al.
International Journal of Antimicrobial Agents|November 24, 2004
Chemotherapeutic efficacy of poly (DL-lactide-co-glycolide) nanoparticle encapsulated antitubercular drugs at sub-therapeutic dose against experimental tuberculosisAnjali Sharma, Rajesh Pandey, Sadhna Sharma, et al.
Tuberculosis (Edinburgh, Scotland)|August 14, 2017
Mycobacterium tuberculosis MymA is a TLR2 agonist that activate macrophages and a T<sub>H</sub>1 responseIti Saraav, Swati Singh, Kirti Pandey, et al.
Pageof 14